Figure 3.
Changes of fasting glycemia with treatment in naive and experienced patients in the whole group and separately for F4 fibrosis patients. EoT: end of treatment; EoT+12w: 12 weeks after the end of treatment.
Changes of fasting glycemia with treatment in naive and experienced patients in the whole group and separately for F4 fibrosis patients. EoT: end of treatment; EoT+12w: 12 weeks after the end of treatment.